Corrigendum to: Optimal hemoglobin A1c levels for screening of diabetes and prediabetes in the Japanese population (Journal of Diabetes Research (2015) 2015 (932057) DOI: 10.1155/2015/932057);Optimal hemoglobin a1c levels for screening of diabetes and prediabetes in the japanese population

Journal of Diabetes Research

Volumn 2015, Issue , 2015, Pages

  Shimodaira, Masanori ^a   Okaniwa, Shinji ^a   Hanyu, Norinao ^a   Nakayama, Tomohiro ^b  

^a Iida Municipal Hospital   (Japan)

^b NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CREATININE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; ARTICLE; AUTOANALYZER; CHOLESTEROL BLOOD LEVEL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; FALSE NEGATIVE RESULT; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; JAPAN; MASS SCREENING; METABOLISM; MIDDLE AGED; PREDIABETIC STATE;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; DIABETES MELLITUS; FEMALE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; JAPAN; MALE; MASS SCREENING; MIDDLE AGED; PREDIABETIC STATE; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 84934983052     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2017/7072538     Document Type: Erratum

References (25)

1. D.R. Whiting, L. Guariguata, C. Weil, and J. Shaw, "IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030, " Diabetes Research and Clinical Practice, vol. 94, no. 3, pp. 311-321, 2011.
2. S. Wild, G. Roglic, A. Green, R. Sicree, and H. King, "Global prevalence of diabetes: estimates for the year 2000 and projections for 2030, " Diabetes Care, vol. 27, no. 5, pp. 1047-1053, 2004.
3. A. G. Tabák, C. Herder, W. Rathmann, E. J. Brunner, and M. Kivimäki, "Prediabetes: a high-risk state for diabetes development, " The Lancet, vol. 379, no. 9833, pp. 2279-2290, 2012.
4. E. Eschwège, M. A. Charles, D. Simon, N. Thibult, and B. Balkau, "Reproducibilily of the diagnosis of diabetes over a 30-month follow-up: the Paris prospective study, " Diabetes Care, vol. 24, no. 11, pp. 1941-1944, 2001.
5. J. Drzewoski and L. Czupryniak, "Concordance between fasting and 2-h post-glucose challenge criteria for the diagnosis of diabetes mellitus and glucose intolerance in high risk individuals, " Diabetic Medicine, vol. 18, no. 1, pp. 29-31, 2001.
6. International Expert Committee, "International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes, " Diabetes Care, vol. 32, no. 7, pp. 1327-1334, 2009.
7. American Diabetes Association, "Standards of medical care in diabetes-2010, " Diabetes Care, vol. 33, supplement 1, pp. S11-S61, 2009.
8. W. H. Herman, Y. Ma, G. Uwaifo et al., "Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the diabetes prevention program, " Diabetes Care, vol. 30, no. 10, pp. 2453-2457, 2007.
9. 1c, and 1, 5-anhydroglucitol in over 2000 patients with type 2 diabetes, " The Journal of Clinical Endocrinology & Metabolism, vol. 94, no. 5, pp. 1689-1694, 2009.
10. D. C. Ziemer, P. Kolm, W. S. Weintraub et al., "Glucoseindependent, black-white differences in hemoglobin A1c levels: a cross-sectional analysis of 2 studies, " Annals of Internal Medicine, vol. 152, no. 12, pp. 770-777, 2010.
11. American Diabetes Association, "Standards of medical care in diabetes-2014, " Diabetes Care, vol. 37, supplement 1, pp. S14-S80, 2014.
12. S. Matsuo, E. Imai, M. Horio et al., "Revised equations for estimated GFR from serum creatinine in Japan, " American Journal of Kidney Diseases, vol. 53, no. 6, pp. 982-992, 2009.
13. I. Goodall, P. G. Colman, H. G. Schneider, M. McLean, and G. Barker, "Desirable performance standards for HbA1c analysisprecision, accuracy and standardisation: consensus statement of the Australasian Association of Clinical Biochemists (AACB), the Australian Diabetes Society (ADS), the Royal College of Pathologists of Australasia (RCPA), Endocrine Society of Australia (ESA), and theAustralian Diabetes EducatorsAssociation (ADEA), " Clinical Chemistry and Laboratory Medicine, vol. 45, no. 8, pp. 1083-1097, 2007.
14. J. A. Hanley and B. J. McNeil, "The meaning and use of the area under a receiver operating characteristic (ROC) curve, " Radiology, vol. 143, no. 1, pp. 29-36, 1982.
15. A. J. Viera and J. M. Garrett, "Understanding interobserver agreement: the kappa statistic, " Family Medicine, vol. 37, no. 5, pp. 360-363, 2005.
16. American Diabetes Association, "Diagnosis and classification of diabetes mellitus, " Diabetes Care, vol. 33, supplement 1, pp. S62-S69, 2009.
17. C. D. Saudek, W. H. Herman, D. B. Sacks, R. M. Bergenstal, D. Edelman, and M. B. Davidson, "A new look at screening and diagnosing diabetes mellitus, " Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 7, pp. 2447-2453, 2008.
18. S. Colagiuri, Z. Hussain, P. Zimmet, and A. Cameron, "Screening for type 2 diabetes and impaired glucose metabolism: the Australian experience, " Diabetes Care, vol. 27, no. 2, pp. 367-371, 2004.
19. C. L. Rohlfing, R. R. Little, and H. M. Wiedmeyer, "Use of GHb (HbA1c) in screening for undiagnosed diabetes in the U.S. population, " Diabetes Care, vol. 23, no. 2, pp. 187-191, 2000.
20. G. T. C. Ko, J. C. N. Chan, V. T. F. Yeung et al., "Combined use of a fasting plasma glucose concentration and HbA1c or fructosamine predicts the likelihood of having diabetes in highrisk subjects, " Diabetes Care, vol. 21, no. 8, pp. 1221-1225, 1998.
21. F. Favier, I. Jaussent, N. Le Moullec et al., "Prevalence of Type 2 diabetes and central adiposity in La Réunion Island, the REDIA Study, " Diabetes Research and Clinical Practice, vol. 67, no. 3, pp. 234-242, 2005.
22. K. Inoue, M. Matsumoto, and Y. Kobayashi, "The combination of fasting plasma glucose and glycosylated hemoglobin predicts type 2 diabetes in Japanese workers, " Diabetes Research and Clinical Practice, vol. 77, no. 3, pp. 451-458, 2007.
23. C. M. Bennett, M. Guo, and S. C. Dharmage, "HbA1c as a screening tool for detection of Type 2 diabetes: a systematic review, " Diabetic Medicine, vol. 24, no. 4, pp. 333-343, 2007.
24. X. H. Zhou, L. N. Ji, Y. Y. Luo, X. Y. Zhang, X. Y. Han, and Q. Qiao, "Performance of HbA1c for detecting newly diagnosed diabetes and pre-diabetes in Chinese communities living in Beijing, " Diabetic Medicine, vol. 26, no. 12, pp. 1262-1268, 2009.
25. H. Lee, J.-Y. Oh, Y.-A. Sung et al., "Optimal hemoglobin A1C cutoff value for diagnosing type 2 diabetes mellitus in Korean adults, " Diabetes Research and Clinical Practice, vol. 99, no. 2, pp. 231-236, 2013.